These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 6480837)

  • 1. Cross-sectional study on the psychosocial factors, the severity of depression, and coping strategies among patients attempting suicide.
    Saharia B; Ghosh S
    Indian J Psychiatry; 2024 Jan; 66(1):26-35. PubMed ID: 38419923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keeping it together: The role of social integration on health and psychological well-being among individuals with multiple sclerosis.
    Latinsky-Ortiz EM; Strober LB
    Health Soc Care Community; 2022 Nov; 30(6):e4074-e4085. PubMed ID: 35322484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A focus group study to inform design of a symptom management intervention for adults with atrial fibrillation.
    Hilow HJ; Whibley D; Kratz AL; Ghanbari H
    Cardiovasc Digit Health J; 2021 Oct; 2(5):246-255. PubMed ID: 35265916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotic and commensal gut microbial therapies in multiple sclerosis and its animal models: a comprehensive review.
    Blais LL; Montgomery TL; Amiel E; Deming PB; Krementsov DN
    Gut Microbes; 2021; 13(1):1943289. PubMed ID: 34264791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effectiveness of a tailored cognitive behavioural therapy with a supportive listening intervention for depression in those newly diagnosed with multiple sclerosis (the ACTION-MS trial): protocol of an assessor-blinded, active comparator, randomised controlled trial.
    Kiropoulos L; Kilpatrick T; Kalincik T; Churilov L; McDonald E; Wijeratne T; Threader J; Rozenblat V; O’Brien-Simpson N; Van Der Walt A; Taylor L
    Trials; 2020 Jan; 21(1):100. PubMed ID: 31959224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive multiple sclerosis and mood disorders.
    Lorefice L; Fenu G; Trincas G; Moro MF; Frau J; Coghe GC; Cocco E; Marrosu MG; Carta MG
    Neurol Sci; 2015 Sep; 36(9):1625-31. PubMed ID: 25899424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence-based guideline: assessment and management of psychiatric disorders in individuals with MS: report of the Guideline Development Subcommittee of the American Academy of Neurology.
    Minden SL; Feinstein A; Kalb RC; Miller D; Mohr DC; Patten SB; Bever C; Schiffer RB; Gronseth GS; Narayanaswami P;
    Neurology; 2014 Jan; 82(2):174-81. PubMed ID: 24376275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of health services in people with multiple sclerosis with and without depressive symptoms: a two-year prospective study.
    Ytterberg C; Lundqvist S; Johansson S
    BMC Health Serv Res; 2013 Sep; 13():365. PubMed ID: 24074396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptom burden in individuals with cerebral palsy.
    Hirsh AT; Gallegos JC; Gertz KJ; Engel JM; Jensen MP
    J Rehabil Res Dev; 2010; 47(9):863-76. PubMed ID: 21174251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocol for the saMS trial (supportive adjustment for multiple sclerosis): a randomized controlled trial comparing cognitive behavioral therapy to supportive listening for adjustment to multiple sclerosis.
    Moss-Morris R; Dennison L; Yardley L; Landau S; Roche S; McCrone P; Chalder T
    BMC Neurol; 2009 Aug; 9():45. PubMed ID: 19698171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression and immunity: inflammation and depressive symptoms in multiple sclerosis.
    Gold SM; Irwin MR
    Immunol Allergy Clin North Am; 2009 May; 29(2):309-20. PubMed ID: 19389584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychological interventions for multiple sclerosis.
    Thomas PW; Thomas S; Hillier C; Galvin K; Baker R
    Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD004431. PubMed ID: 16437487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurorehabilitation in multiple sclerosis--what is the evidence-base?
    Kesselring J
    J Neurol; 2004 Sep; 251 Suppl 4():IV25-9. PubMed ID: 15378304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimism and adaptation to multiple sclerosis: what does optimism mean?
    Fournier M; de Ridder D; Bensing J
    J Behav Med; 1999 Aug; 22(4):303-26. PubMed ID: 10495965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social support among African-American adults with diabetes. Part 1: Theoretical framework.
    Ford ME; Tilley BC; McDonald PE
    J Natl Med Assoc; 1998 Jun; 90(6):361-5. PubMed ID: 9640907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sexual dysfunction in relapsing-remitting multiple sclerosis: magnetic resonance imaging, clinical, and psychological correlates.
    Barak Y; Achiron A; Elizur A; Gabbay U; Noy S; Sarova-Pinhas I
    J Psychiatry Neurosci; 1996 Jul; 21(4):255-8. PubMed ID: 8754594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing advanced multiple sclerosis.
    Teasell RW
    Can Fam Physician; 1993 May; 39():1127-30, 1133-4, 1137-41. PubMed ID: 8499793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis: correlation of anxiety, physical impairment and cognitive dysfunction.
    Stenager E; Knudsen L; Jensen K
    Ital J Neurol Sci; 1994 Mar; 15(2):97-101. PubMed ID: 8056558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression in multiple sclerosis as a function of length and severity of illness, age, remissions, and perceived social support.
    McIvor GP; Riklan M; Reznikoff M
    J Clin Psychol; 1984 Jul; 40(4):1028-33. PubMed ID: 6480837
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.